U.S. Patent Office Grants Interim Extension for NUVIGIL Patent

Summary

The U.S. Patent and Trademark Office has issued an order granting a one-year interim extension under the patent term adjustment provisions for U.S. Patent No. 4,927,855, which covers the medication NUVIGIL (armodafinil).